Beneficial effect of human albumin on neonatal cerebral edema

American Journal of Therapeutics

Volumn 8, Issue 4, 2001, Pages 253-254

  Gürkan, Fuat ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

SERUM ALBUMIN;

APGAR SCORE; ARTICLE; BRAIN EDEMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LENGTH OF STAY; MALE; NEWBORN; NEWBORN HYPOXIA; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

APGAR SCORE; ASPHYXIA NEONATORUM; BRAIN EDEMA; FEMALE; HUMANS; INFANT, NEWBORN; LENGTH OF STAY; MALE; SERUM ALBUMIN; TREATMENT OUTCOME;

EID: 0035403212     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-200107000-00008     Document Type: Article

References (5)

1. Rapoport ST: Permeability and osmotic properties of the blood brain barrier. In: Blood-Brain-Barrier in Physiology and Medicine. (Ed. Rapoport ST), Raven Press, New York, 1976, p87.
2. Belayev L, Busto R, Zhao W, et al: Effect of delayed albumin hemodilution on infarction volume and BE after transient middle cerebral artery, occlusion in rats. J Neurosurg 1997;87:595-601.
3. Onal C, Unal F, Turantan MI, et al: The effect of intraventricular albumin in experimental brain oedema. Acta Neurochir 1997;139:661-668.
4. Asgeirsson B, Grande PO, Nordstrom CH: A new therapy of post-trauma brain oedema based on haemodynamic principles for brain volume regulation. Intensive Care Med 1994;20:260-267.
5. Grande PO, Nordstrom CH, Asgeirsson B: Current alternative therapy of post-traumatic brain edema. Nord Med 1994;109:157-159.